Invitrogen Takes Minority Stake in Q Therapeutics | GenomeWeb
NEW YORK (GenomeWeb News) – Invitrogen today announced that it has made a minority investment in cell therapy firm Q Therapeutics.
 
The amount of the investment and the stake Invitrogen now holds in the Salt Lake City-based biopharmaceutical company were not disclosed.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.